Simplex Trading
FLNA

Simplex Trading’s Filana Therapeutics FLNA Stock Holding History

Simplex Trading’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75.7K Sell
44,800
-156,100
-78% -$321K ﹤0.01% 5401
2025
Q4 		$408K Buy
200,900
+90,700
+82% +$290K ﹤0.01% 3505
2025
Q3 		$320K Buy
110,200
+29,000
+36% +$66.7K ﹤0.01% 4373
2025
Q2 		$146K Buy
81,200
+10,400
+15% +$18.5K ﹤0.01% 4834
2025
Q1 		$106K Sell
70,800
-380,000
-84% -$959K ﹤0.01% 4996
2024
Q4 		$1.06M Buy
450,800
+112,900
+33% +$1.98M ﹤0.01% 2779
2024
Q3 		$9.94M Buy
337,900
+238,400
+240% +$5.49M 0.01% 1036
2024
Q2 		$1.23M Buy
99,500
+32,200
+48% +$679K ﹤0.01% 2705
2024
Q1 		$518K Sell
67,300
-67,800
-50% -$1.56M ﹤0.01% 3831
2023
Q4 		$562K Buy
135,100
+48,500
+56% +$1.02M ﹤0.01% 3565
2023
Q3 		$1.44M Sell
86,600
-24,300
-22% -$482K ﹤0.01% 2351
2023
Q2 		$2.72M Buy
110,900
+48,000
+76% +$1.16M ﹤0.01% 1728
2023
Q1 		$1.52M Sell
62,900
-145,100
-70% -$4.02M ﹤0.01% 2184
2022
Q4 		$6.14M Sell
208,000
-122,100
-37% -$4.39M 0.01% 1104
2022
Q3 		$13.8M Buy
330,100
+122,500
+59% +$3.31M 0.02% 653
2022
Q2 		$5.84M Sell
207,600
-44,300
-18% -$1.12M 0.01% 1058
2022
Q1 		$9.36M Buy
251,900
+89,500
+55% +$3.79M 0.01% 870
2021
Q4 		$7.1M Buy
162,400
+39,100
+32% +$2.05M 0.01% 988
2021
Q3 		$10.9M Sell
123,300
-800
-0.6% -$66.8K 0.01% 684
2021
Q2 		$10.6M Buy
124,100
+123,557
+22,755% +$6.62M 0.01% 691
2021
Q1 		$2.44M Buy
+543
New +$21.4K ﹤0.01% 1408
2020
Q3 		– Sell
-252
Closed -$77K – 8416
2020
Q2 		$77K Buy
252
+136
+117% +$617 ﹤0.01% 5078
2020
Q1 		$47K Buy
+116
New +$768 ﹤0.01% 5199
2017
Q2 		– Sell
-8
Closed -$21K – 6701
2017
Q1 		$21K Buy
+8
New +$36 ﹤0.01% 3210
2016
Q4 		– Sell
-7
Closed -$11K – 6431
2016
Q3 		$11K Buy
7
+3
+75% +$50 ﹤0.01% 3543
2016
Q2 		$6K Buy
+4
New +$63 ﹤0.01% 4114

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Simplex Trading's FLNA Position: Q1 2026 in Review

Simplex Trading reduced its Filana Therapeutics (FLNA) stake by 19% in Q1 2026, selling an estimated $68.1K and leaving 139,995 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #4095.

Simplex Trading first reported a position in FLNA in Q1 2015 and has held it in 29 quarters since. The position peaked at $5.05M in Q3 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Simplex Trading held 139,995 shares of Filana Therapeutics worth $237K as of Q1 2026.
  • Simplex Trading sold 33,070 Filana Therapeutics shares in Q1 2026, an estimated $68.1K.
  • Filana Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4095 holding.
  • Simplex Trading first reported a position in Filana Therapeutics in Q1 2015 and has held it in 29 quarters since.
  • Simplex Trading's Filana Therapeutics position peaked at $5.05M in Q3 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.